Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1

Tyrosinemia type 1 (TT1) is a rare metabolic disease caused by a defect in tyrosine catabolism. TT1 is clinically characterized by acute liver failure, development of hepatocellular carcinoma, renal and neurological problems, and consequently an extremely poor outcome. This review showed that the in...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ginkel, Willem G., Rodenburg, Iris L., Harding, Cary O., Hollak, Carla E. M., Heiner-Fokkema, M. Rebecca, van Spronsen, Francjan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Leading Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885500/
https://www.ncbi.nlm.nih.gov/pubmed/31667718
http://dx.doi.org/10.1007/s40272-019-00364-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885500/
https://www.ncbi.nlm.nih.gov/pubmed/31667718
http://dx.doi.org/10.1007/s40272-019-00364-4

Ejemplares similares